Mizuho raises Fiserv stock target to $259, maintains outperform
Securities has increased its price target on Fiserv (NYSE:FI) shares (NYSE: FISV), a leading global provider of payments and financial services technology solutions, to $259.00, up from the previous ...
D.A. Davidson Reaffirms Their Buy Rating on Symbotic (SYM)
D.A. Davidson analyst Matt Summerville maintained a Buy rating on Symbotic (SYM – Research Report) today and set a price target of $35.00. The ...
TD Cowen Sticks to Its Buy Rating for Symbotic (SYM)
TD Cowen analyst Joseph C Giordano maintained a Buy rating on Symbotic (SYM – Research Report) today and set a price target of $45.00. The ...
Spire Wealth Management Raises Stock Position in CVS Health Co. (NYSE:CVS)
Spire Wealth Management lifted its holdings in CVS Health Co. (NYSE:CVS – Free Report) by 27.0% in the fourth quarter, ...
Thursday’s analyst upgrades and downgrades
Seeing “growth on hiatus,” Mr. Bir reduced his own forecast for 2025 and 2026 “with revisions mainly for longer lease-up ...
What is William Blair’s Forecast for TWST Q2 Earnings?
Research analysts at William Blair issued their Q2 2026 earnings per share (EPS) estimates for Twist Bioscience in a report ...
Twist Bioscience president Finn sells $140,406 in stock
Twist Bioscience Corp (NASDAQ:TWST), a biotechnology company with a market capitalization of $3.2 billion, recently disclosed that its President and Chief Operating Officer, Finn Patrick John, ...